Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Pharma Watch

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

This week, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in the treatment of rare genetic diseases surrounding obesity, announced the U.S. […]

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
3 months ago
Share

Pfizer Announces FDA Priority Review; EMA Acceptance of Regulatory Submission for Abrocitinib in Patients Over 12 Years of Age with Moderate to Severe Atopic Dermatitis

Pfizer announced the U.S. Food and Drug Administration (FDA) accepted for filing and granted Priority Review designation to the company’s […]

Pfizer Announces FDA Priority Review; EMA Acceptance of Regulatory Submission for Abrocitinib in Patients Over 12 Years of Age with Moderate to Severe Atopic Dermatitis
4 months ago
Share

Lilly on the Verge of COVID-19 Monoclonal Antibody EUA Approval First for High Risk Patients with Recent Mild-to-Moderate COVID-19 Diagnosis

TrialSite shared that Eli Lilly’s (Lilly) monoclonal antibody program targeting COVID-19 appeared to be working, at least according to some trial […]

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly
5 months ago
Share

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly

Regeneron reported that subsequent to the New York-based company’s discussions with regulatory authorities, they have submitted a request to the […]

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly
5 months ago
Share

Novavax Taps into the $1.6b in U.S. Fed Award to Fund Phase 3 Clinical Trial in the UK in Pursuit of Euro Filing

Novavax Inc. (Nasdaq: NVAX) has progressed their investigational vaccine product for COVID-19 called NVX-CoV2373 to Phase 3 to evaluate the […]

Novavax Taps into the $1.6b in U.S. Fed Award to Fund Phase 3 Clinical Trial in the UK in Pursuit of Euro Filing
5 months ago
Share

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

Novartis sells medicines for zero-profit

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?
8 months ago
Share

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

Inovio Pharmaceuticals (Nasdaq: INO) reported recent preclinical data summaries for their COVID-19 DNA vaccine called INO-4800 demonstrating promising information. Namely, […]

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models
10 months ago
Share

Ansun Biopharma’s DAS181 Shows Promise in COVID-19 Patients with Respiratory Challenges

Recently, the Wall Street Journal introduced a small, 25-person San Diego-based biotech called Ansun Biophrma (Ansun) reporting on recent success of […]

Ansun Biopharma’s DAS181 Shows Promise in COVID-19 Patients with Respiratory Challenges
10 months ago
Share

‘Unprecedented Times call for Bold Moves’ as Competitive Plasma Firms Unite to Battle COVID-19

CSL Behring and Takeda Pharmaceutical Company have initiated an alliance bringing together the world’s leading plasma companies to focus on […]

‘Unprecedented Times call for Bold Moves’ as Competitive Plasma Firms Unite to Battle COVID-19
11 months ago
Share

Acceleration of First-Patient-First-Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain

Roche recently announce the launch of a global study in collaboration with the U.S. Biomedical Advanced Research and Development Authority […]

Acceleration of First Patient First Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain
11 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.